ISRCTN36901382
Completed
未知
Placebo-controlled assessment of the efficacy of a food supplement in improving face skin conditions and cellulite derived skin imperfections
ROELMI HPC0 sites66 target enrollmentMarch 16, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Fine lines/light wrinkles, dull skin and uneven skin tone and mild to moderate cellulite-derived skin imperfections
- Sponsor
- ROELMI HPC
- Enrollment
- 66
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2023 Results article in https://www.yumedtext.com/files/publish/published-pdf--6-ACED-150.pdf (added 18/12/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Healthy female subjects
- •2\. Age between 35 and 65 (extremes included) years old
- •3\. Phototype I to IV included, according to Fitzpatrick classification
- •4\. Subjects showing fine lines/light wrinkles, dull skin and uneven skin tone
- •5\. Subjects showing mild to moderate cellulite\-derived skin imperfections
- •6\. 10 subjects per group showing visible dark circles
- •7\. 10 subjects per group showing visible eyebags
- •8\. Subjects who have not been involved in any other similar in the last 3 months
- •9\. Subjects registered with Nation Health Service (NHS),
- •10\. Subjects certifying the truthfulness of the personal data disclosed to the investigator
Exclusion Criteria
- •1\. Subject does not meet the inclusion criteria
- •2\. Subjects with acute or chronic diseases able to interfere with the outcome of the study or that are considered dangerous for the subject or incompatible with the study requirements
- •3\. Subjects participating or planning to participate in other clinical trials
- •4\. Subjects deprived of freedom by administrative or legal decision or under guardianship
- •5\. Subjects not able to be contacted in case of emergency
- •6\. Subjects admitted to a health or social facility
- •7\. Subjects planning a hospitalization during the study
- •8\. Subjects who participated in a similar study without respecting an adequate washout period
- •9\. Subjects having an acute, chronic or progressive illness liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
- •10\. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of immune modulation by beta-glucan, a soluble dietary fiber derived from reishi mushroom in healthy adult volunteers, a systemic clinical trialISRCTN48306294Super Beta Glucan Inc., Biomedical Research Division173
Completed
Phase 3
A randomised trial to compare the effectiveness of two antidepressants (escitalopram, a selective serotonin re-uptake inhibitor, SSRI) and (nortriptyline, a tricyclic antidepressant, TCA) compared to placebo for the treatment of depression in patients with Parkinson’s diseaseDepression in patients with Parkinson's diseaseMental and Behavioural DisordersISRCTN48548553niversity College London52
Completed
Not Applicable
To study the effect of tofacitinib along with corticosteroids in patients with acute severe ulcerative colitisAcute severe ulcerative colitis (ASUC)Digestive SystemISRCTN42182437Dayanand Medical College & Hospital104
Completed
Phase 3
Phase III trial of inhaled SNG001 compared to placebo for the treatment of patients hospitalised due to moderate COVID-19COVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN85436698Synairgen Research Ltd623
Completed
Not Applicable
Comparison of two adjunctive locally delivered antibiotic gel regimens for initial therapy in periodontitis patientsTopical antibiotic gels applied adjunctively to subgingival instrumentation in stage III-IV periodontitis patients.Oral HealthISRCTN89207035MegaGen Dental Implant Romania100